Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

RCP President Reponds To New ONS Figures Suggesting That School Pupils Are More Likely To Drink Alcohol If They Live With Other Drinkers, UK
Responding to data in Smoking, drinking and drug use among young people in England, 2008 that suggests the likelihood of a pupil drinking alcohol increases with the number of drinkers per household, Professor Ian Gilmore, President of the Royal College of Physicians said:

Columnist Discusses HIV/AIDS Among Blacks In Washington, D.C.
Columnist George Curry on Tuesday in the Hudson Valley Press discussed how HIV/AIDS is impacting the black community, particularly in Washington, D.C. The piece includes comments from Phill Wilson, CEO of the Black AIDS Institute and C. Virginia Fields, president and CEO of the National Black Leadership Commission on AIDS, who discuss statistics and recommendations to address HIV/AIDS among the black community, including routine HIV testing. Curry writes, "If C. Virginia Fields and other activists get their wish and have [HIV] testing incorporated into routine health testing, that will place a heavier burden on crowded counseling and treatment facilities. But it"s not an insurmountable burden. The question is: Do we have the national will to take on this epidemic?" (7/29).
News of the day
Increasing Costs In Cancer Care Are A Growing Factor In Decision-Making For Patients, Physicians, Society
When a cancer patient and his or her doctor discuss the value of a treatment option, the conversation usually centers on a consideration of the treatment"s medical benefits versus its possible side effects for the patient. Increasingly, however, as the already high costs of cancer care continue to rise, a full view of the patient"s welfare must also take into account the economic impact of the treatment on the patient and his or her family.
Endocrinology

ADVTX Announces New Treatment For Bleeding After Nuclear Exposure

Advanced Therapeutics & Co. (ADVTX) announced that Fibrinoplate-S™ has shown efficacy in reducing the bleeding in animals exposed to extreme doses of radiation. Survivors of a nuclear event or a dirty bomb explosion will have similar damage from the ionizing radiation of such bombs. "Acute radiation can severely damage the bone marrow," Richard Yen, Ph.D., M.D., CEO of ADVTX explained. "While existing medications can boost the production of red cells and white cells from the recovering bone marrow, there is no effective treatment for low concentrations of platelets except through platelet transfusion. Donor platelets, however, may not be available or adequately screened for pathogens during times of distress." Viable Alternative to Platelet Transfusion ADVTX Fibrinoplate-S, a suspension formulation of human albumin spheres coated with a coagulation factor (fibrinogen), mimics the action of activated platelets. Random clots have not been observed even as bleeding improves after the administration of Fibrinoplate-S. In preclinical trials, Fibrinoplate-S reduced bleeding within 2 hours after a bolus intravenous administration in test subjects with less than 1% of the normal platelet count. The beneficial effects last at least 24 hours. There is no need to match the recipients" blood types. Fibrinoplate-S can be given to a large number of patients quickly. Availability ADVTX can scale up its production of Fibrinoplate-S quickly. Government agencies may include Fibrinoplate-S in their emergency response plans by submitting a "pre-EUA" (pre-Emergency Use Approval) to the US FDA. Licensing outside the United States is available. Visit http://www.ADVTX.com. Advanced Therapeutics & Co.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009